Erlotinib

Therapeutic Group

Anti-neoplastics

Indication Dosage

Indication:

Erlotinib is a medication used to treat certain types of lung cancer. It is prescribed by doctors to help slow down the growth of cancer cells in the lungs, especially in cases where the cancer has spread or is advanced.

Dosage:

Treatment Of Locally Advanced Or Metastatic Non-small Cell Lung Cancer After Failure Of Previous Chemotherapy Or Monotherapy After Four Cycles Of Platinum-based Chemotherapy For Maintenance: 

  • Adult: 150 Mg Once Daily 

Treatment Of Metastatic Pancreatic Cancer (in Combination): 

  • Adult: 100 Mg Once Daily

Content

  • Tab 25mg /100mg /150mg: Erlotinib As Hci 25mg /100mg /150mg.

Pregnancy

Positive Evidence Of Risk: Avoid

Stability

  • Protein Kinase Inhibitor

Contra Indications

  • None Known

Precautions

  • None Known

Lactation

  • Contraindicated. Discontinue Breast-feeding.

Side Effects

  • Abdominal Pain
  • Anorexia
  • Conjunctivitis
  • Depression
  • Diarrhoea
  • Dry Skin
  • Dyspepsia
  • Fatigue
  • Flatulence
  • Headache
  • Neuropathy
  • Pruritus
  • Rigor
  • Gi Perforation
  • Interstitial Lung Disease (discontinue). Rare Hepatic Failure
  • Alopecia
  • Bone-marrow Suppression
  • Hyperuricaemia
  • Nausea
  • Oral Mucositis
  • Thromboembolism
  • Tumourlysis Syndrome
  • Vomiting

Available Brands